State of the art in muscle glycogenoses

The recognition of a series of metabolic/enzymatic dysfunctions in glycogenoses has allowed new therapeutic advances for their treatment due to the development of recombinant enzyme. A recent advance appears enzymatic replacement therapy (ERT) in glycogenosis type II in both infantile, juvenile and...

Descripción completa

Detalles Bibliográficos
Autor principal: Angelini, C.
Formato: Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040590/
https://www.ncbi.nlm.nih.gov/pubmed/21314016
_version_ 1782198337849524224
author Angelini, C.
author_facet Angelini, C.
author_sort Angelini, C.
collection PubMed
description The recognition of a series of metabolic/enzymatic dysfunctions in glycogenoses has allowed new therapeutic advances for their treatment due to the development of recombinant enzyme. A recent advance appears enzymatic replacement therapy (ERT) in glycogenosis type II in both infantile, juvenile and adult form. Targeted manipulation of diet has been tried both in glycogenosis type II (Pompe disease) and type V (Mc Ardle disease).
format Text
id pubmed-3040590
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Pacini Editore SpA
record_format MEDLINE/PubMed
spelling pubmed-30405902011-08-01 State of the art in muscle glycogenoses Angelini, C. Acta Myol Original Articles The recognition of a series of metabolic/enzymatic dysfunctions in glycogenoses has allowed new therapeutic advances for their treatment due to the development of recombinant enzyme. A recent advance appears enzymatic replacement therapy (ERT) in glycogenosis type II in both infantile, juvenile and adult form. Targeted manipulation of diet has been tried both in glycogenosis type II (Pompe disease) and type V (Mc Ardle disease). Pacini Editore SpA 2010-10 /pmc/articles/PMC3040590/ /pubmed/21314016 Text en Gaetano Conte Academy, Naples, Italy http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Articles
Angelini, C.
State of the art in muscle glycogenoses
title State of the art in muscle glycogenoses
title_full State of the art in muscle glycogenoses
title_fullStr State of the art in muscle glycogenoses
title_full_unstemmed State of the art in muscle glycogenoses
title_short State of the art in muscle glycogenoses
title_sort state of the art in muscle glycogenoses
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040590/
https://www.ncbi.nlm.nih.gov/pubmed/21314016
work_keys_str_mv AT angelinic stateoftheartinmuscleglycogenoses

Ejemplares similares